{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:21:34Z","timestamp":1791404494638,"version":"4.3.3"},"reference-count":312,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.intimp.2024.112232","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T08:04:59Z","timestamp":1716969899000},"page":"112232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["An update on existing therapeutic options and status of novel anti-metastatic agents in breast cancer: Elucidating the molecular mechanisms underlying the pleiotropic action of Withania somnifera (Indian ginseng) in breast cancer attenuation"],"prefix":"10.1016","volume":"136","author":[{"given":"Aditi","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumana","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahabjada","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchal","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsin","family":"Ali Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112232_b0005","unstructured":"Mary SBJ (2022) Breast cancer awareness month: Stay vigilant, stay healthy. The Hindu. Available from: https:\/\/www.thehindu.com\/news\/national\/karnataka\/incidence-of-cancer-was-higher-among-women-in-2022-in-karnataka-with-breast-cancer-contributin295\/article66467731.ece. Accessed 26 October 2023."},{"key":"10.1016\/j.intimp.2024.112232_b0010","unstructured":"Centers for Disease Control and Prevention. Basic Information About Breast Cancer. Available from: https:\/\/www.cdc.gov\/cancer\/breast\/basic_info\/index.htm#:\u223c:text=Each%20year%20in%20the%20United,cancer%20than%20all%20other%20women. Accessed 10 April 2024."},{"key":"10.1016\/j.intimp.2024.112232_b0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.intimp.2024.112232_b0020","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2024.112232_b0025","unstructured":"Khan YS, Sajjad H (2019) Anatomy, thorax, mammary gland."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1469-7580.2005.00417.x","article-title":"Anatomy of the lactating human breast redefined with ultrasound imaging","volume":"206","author":"Ramsay","year":"2005","journal-title":"J. Anatomy"},{"key":"10.1016\/j.intimp.2024.112232_b0035","article-title":"Endogenous voltage potentials and the microenvironment: bioelectric signals that reveal, induce and normalize cancer","author":"Chernet","year":"2013","journal-title":"J. Clin. Exp. Oncol."},{"issue":"24","key":"10.1016\/j.intimp.2024.112232_b0040","doi-asserted-by":"crossref","first-page":"13422","DOI":"10.3390\/ijms222413422","article-title":"Molecular morphology and function of stromal cells","volume":"22","author":"Manetti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b0045","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4161\/cam.20875","article-title":"Mesenchymal stem cells in tumor development: emerging roles and concepts","volume":"6","author":"Cuiffo","year":"2012","journal-title":"Cell Adh. Migr."},{"key":"10.1016\/j.intimp.2024.112232_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.661532","article-title":"The therapeutic potential of mesenchymal stromal cells for regenerative medicine: current knowledge and future understandings","volume":"9","author":"Merimi","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112232_b0055","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"issue":"45","key":"10.1016\/j.intimp.2024.112232_b0060","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ijc.11403","article-title":"Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor \u03b1","volume":"107","author":"Kawai","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2024.112232_b0070","first-page":"140","article-title":"Male breast cancer: A review","volume":"3","author":"Fentiman","year":"2009","journal-title":"E Cancer Med. Sci."},{"key":"10.1016\/j.intimp.2024.112232_b0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/B:BREA.0000010701.08825.2d","article-title":"Is male breast cancer similar or different from female breast cancer?","volume":"83","author":"Anderson","year":"2004","journal-title":"Br. Cancer Res. Treat."},{"key":"10.1016\/j.intimp.2024.112232_b0080","doi-asserted-by":"crossref","unstructured":"Khare VS, Huda F, Misra S, Amulya KR, Raj N, Karn S, Basu S (2024) Male Breast Cancer: An Updated Review of Patient Characteristics, Genetics, and Outcome. Int J Breast Cancer 2024.","DOI":"10.1155\/2024\/9003572"},{"issue":"2","key":"10.1016\/j.intimp.2024.112232_b0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-008-0053-y","article-title":"The rising incidence of male breast cancer","volume":"115","author":"Speirs","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.intimp.2024.112232_b0090","unstructured":"Khattab A, Kashyap S, Monga DK (2024) Male Breast Cancer. [Updated 2022 Sep 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526036\/."},{"key":"10.1016\/j.intimp.2024.112232_b0095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<629::AID-CNCR13>3.0.CO;2-V","article-title":"Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955\u20131996","volume":"85","author":"Goss","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0100","first-page":"8","article-title":"Cancer statistics","volume":"54","author":"Ahmedin Jemal","year":"2004","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b0105","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4103\/0019-509X.104484","article-title":"Male breast cancer in Indian patients: is it the same?","volume":"49","author":"Chikaraddi","year":"2012","journal-title":"Indian J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/0973-1482.16087","article-title":"Breast Cancer in males: a pgimer experience","volume":"1","author":"Rai","year":"2005","journal-title":"J. Cancer Res. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b0115","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/0256-4947.55314","article-title":"Clinicopathological study of male breast carcinoma: 24 years of experience","volume":"29","author":"Shah","year":"2009","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.intimp.2024.112232_b0120","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.2910530403","article-title":"Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors","volume":"53","author":"Sasco","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2024.112232_b0125","first-page":"489","article-title":"Carcinoma of the male breast in Mulago Hospital, Kampala","volume":"55","author":"Ojara","year":"1978","journal-title":"East Afr. Med. J."},{"key":"10.1016\/j.intimp.2024.112232_b0130","first-page":"176","article-title":"Carcinoma of the male breast in Zambia","volume":"49","author":"Bhagwandin","year":"1972","journal-title":"East Afr. Med. J."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b0135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/028418601750288181","article-title":"Risk Factors for male breast cancer? A case-control study from Scandinavia","volume":"40","author":"Ewertz","year":"2001","journal-title":"Acta Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112232_b0140","first-page":"1079","article-title":"Study of a single BRCA2 mutation with high carrier frequency in a small population","volume":"60","author":"Thorlacius","year":"1997","journal-title":"Am. J. Human Genetics"},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0145","article-title":"Low-penetrance susceptibility to breast cancer due to CHEK2* 1100delC in noncarriers of BRCA1 or BRCA2 mutations","volume":"31","author":"Meijers-Heijboer","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2024.112232_b0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1021369508561","article-title":"Androgen receptor gene alterations in Finnish male breast cancer","volume":"77","author":"Syrj\u00e4koski","year":"2003","journal-title":"Breast Cancer Res. Treatment"},{"issue":"16","key":"10.1016\/j.intimp.2024.112232_b0155","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.ejca.2004.07.012","article-title":"A gene-environment interaction between occupation and BRCA1\/BRCA2 mutations in male breast cancer?","volume":"40","author":"Palli","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.intimp.2024.112232_b0160","first-page":"371","article-title":"Risk factors for male breast cancer","volume":"74","author":"Mabuchi","year":"1985","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b0165","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ijc.2910450415","article-title":"Risk factors for male breast cancer: A Franco-Swiss case-control study","volume":"45","author":"Lenfant-Pejovic","year":"1990","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2024.112232_b0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/jama.1951.03670010011002","article-title":"Bilateral carcinoma of male breast after estrogen therapy","volume":"146","author":"McClure","year":"1951","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2024.112232_b0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.2.5597.83","article-title":"Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics","volume":"2","author":"Symmers","year":"1968","journal-title":"Br. Med. J."},{"key":"10.1016\/j.intimp.2024.112232_b0180","first-page":"269","article-title":"Risk factors for male breast cancer (United States)","volume":"9","author":"Hsing","year":"1998","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.intimp.2024.112232_b0185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00008469-200206000-00009","article-title":"Risk factors for male breast cancer in Canada, 1994\u2013198","volume":"11","author":"Johnson","year":"2002","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.intimp.2024.112232_b0190","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/bjc.1983.208","article-title":"The sex hormone profile of male patients with breast cancer","volume":"48","author":"Nirmul","year":"1983","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2024.112232_b0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/030089169007600106","article-title":"Hormones in male breast cancer","volume":"76","author":"Ballerini","year":"1990","journal-title":"Tumori"},{"key":"10.1016\/j.intimp.2024.112232_b0200","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1096-9098(199701)64:1<74::AID-JSO14>3.0.CO;2-W","article-title":"Pituitary adenoma and bilateral male breast cancer: an unusual association","volume":"64","author":"Volm","year":"1997","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.intimp.2024.112232_b0205","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/BF03351047","article-title":"Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year old male","volume":"24","author":"Forloni","year":"2001","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.intimp.2024.112232_b0210","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02967643","article-title":"Synchronous bilateral non-invasive ductal carcinoma of the male breast: A case report","volume":"10","author":"Okada","year":"2003","journal-title":"Breast Cancer"},{"key":"10.1016\/j.intimp.2024.112232_b0215","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F (2020) Global Cancer Obser-Vatory: Cancer Today Int Agency Res Cancer; Lyon, France (Accessed on 9 July 2021). Available from: https:\/\/gco.iarc.fr\/today."},{"key":"10.1016\/j.intimp.2024.112232_b0220","unstructured":"Ferlay J, Laversanne M, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F (2020) Int Agency Res Cancer; Lyon, France (Accessed on 9 July 2021). Global Cancer Observatory: Cancer Tomorrow. Available online: https:\/\/gco.iarc.fr\/tomorrow."},{"key":"10.1016\/j.intimp.2024.112232_b0225","unstructured":"Int Agency Res Cancer India Source: Globocan 2020. (Accessed on 11 June 2021). Available from: https:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/356-india-fact-sheets.pdf."},{"key":"10.1016\/j.intimp.2024.112232_b0230","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMp0708307","article-title":"Westernizing women\u2019s risks? Breast cancer in lower-income countries","volume":"358","author":"Porter","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.intimp.2024.112232_b0235","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.956839","article-title":"Epigenetic modifications: Basic mechanisms and role in cardiovascular disease","volume":"123","author":"Handy","year":"2011","journal-title":"Circulation"},{"issue":"5895","key":"10.1016\/j.intimp.2024.112232_b0240","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/301089a0","article-title":"Hypomethylation distinguishes genes of some human cancers from their normal counterparts","volume":"301","author":"Feinberg","year":"1983","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.intimp.2024.112232_b0245","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome - biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2024.112232_b0250","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/medicina56120687","article-title":"Ayurveda and epigenetics","volume":"56","author":"Sharma","year":"2020","journal-title":"Medicina"},{"key":"10.1016\/j.intimp.2024.112232_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.971288","article-title":"Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies","volume":"12","author":"Thakur","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b0260","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/mnfr.201501063","article-title":"Epigenetics of breast cancer: Modifying role of environmental and bioactive food compounds","volume":"60","author":"Romagnolo","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b0265","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.molonc.2010.04.002","article-title":"The epigenetics of breast cancer","volume":"4","author":"Jovanovic","year":"2010","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0270","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ijc.29684","article-title":"Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes","volume":"138","author":"Gy\u0151rffy","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2024.112232_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr2590","article-title":"Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns","volume":"12","author":"Holm","year":"2010","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b0280","first-page":"1432","article-title":"CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer","volume":"6","author":"Yan","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.112232_b0285","first-page":"805","article-title":"Methylation of estrogen and progesterone receptor gene 5'CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors","volume":"2","author":"Lapidus","year":"1996","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2024.112232_b0290","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.3390\/cancers12113088","article-title":"DNA methylation and breast cancer risk: an epigenome-wide study of normal breast tissue and blood","volume":"12","author":"Ennour-Idrissi","year":"2020","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.intimp.2024.112232_b0295","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/emmm.201100801","article-title":"DNA methylation profiling reveals a predominant immune component in breast cancers","volume":"3","author":"Dedeurwaerder","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.intimp.2024.112232_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.529386","article-title":"Integrative analysis of DNA methylation and gene expression to determine specific diagnostic biomarkers and prognostic biomarkers of breast cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0305","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12885-019-5403-0","article-title":"Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers","volume":"19","author":"de Almeida","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0310","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1038\/s41467-021-25661-w","article-title":"DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation","volume":"12","author":"Batra","year":"2021","journal-title":"Nat. Comm."},{"issue":"36","key":"10.1016\/j.intimp.2024.112232_b0315","doi-asserted-by":"crossref","first-page":"25893","DOI":"10.1074\/jbc.M603140200","article-title":"Reconstitution and mechanism of the stimulation of de novo methylation by human DNMT3L","volume":"281","author":"Kareta","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b0320","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","article-title":"DNA Methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development","volume":"99","author":"Okano","year":"1999","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.intimp.2024.112232_b0325","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg1655","article-title":"DNA Methylation and human disease","volume":"6","author":"Robertson","year":"2005","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0330","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13073-015-0134-6","article-title":"TET proteins and the control of cytosine demethylation in cancer","volume":"7","author":"Scourzic","year":"2015","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0335","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/embor.2011.233","article-title":"DNA Methylation: TET proteins-guardians of CpG islands?","volume":"13","author":"Williams","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.intimp.2024.112232_b0340","doi-asserted-by":"crossref","unstructured":"Chandramouly G (2022) Gadd45 in DNA demethylation and DNA repair. In: Zaidi MR, Liebermann DA, editors. Gadd45 stress sensor genes. (Philadelphia, PA, USA: Springer International Publishing: Cham) 55-67.","DOI":"10.1007\/978-3-030-94804-7_4"},{"key":"10.1016\/j.intimp.2024.112232_b0345","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-4614-8289-5_3","article-title":"Gadd45 proteins: Key players of repair-mediated DNA demethylation","volume":"793","author":"Sch\u00e4fer","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21030870","article-title":"Interplay between BRCA1 and GADD45A and its potential for nucleotide excision repair in breast cancer pathogenesis","volume":"21","author":"Pietrasik","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.intimp.2024.112232_b0355","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1038\/sj.onc.1208464","article-title":"Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer","volume":"24","author":"Wang","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2024.112232_b0360","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.gde.2016.01.004","article-title":"Portraits of TET-mediated DNA hydroxymethylation in cancer","volume":"36","author":"Jeschke","year":"2016","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"32","key":"10.1016\/j.intimp.2024.112232_b0365","doi-asserted-by":"crossref","first-page":"E2977","DOI":"10.1073\/pnas.1301021110","article-title":"Activation-induced cytidine deaminase (AID) is necessary for the epithelial\u2013mesenchymal transition in mammary epithelial cells","volume":"110","author":"Mu\u00f1oz","year":"2013","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"50","key":"10.1016\/j.intimp.2024.112232_b0370","doi-asserted-by":"crossref","first-page":"52353","DOI":"10.1074\/jbc.M407695200","article-title":"Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: Implications For Epigenetic Reprogramming*","volume":"279","author":"Morgan","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"7284","key":"10.1016\/j.intimp.2024.112232_b0375","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nature08829","article-title":"Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency","volume":"463","author":"Popp","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b0380","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cell.2011.03.022","article-title":"Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain","volume":"145","author":"Guo","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112232_b0385","doi-asserted-by":"crossref","first-page":"e2100190","DOI":"10.1200\/PO.21.00190","article-title":"Apolipoprotein b mRNA-editing catalytic polypeptide-Like-Induced protein changes in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer throughout disease progression","volume":"6","author":"Bos","year":"2022","journal-title":"JCO Precis. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0390","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1158\/2326-6066.CIR-21-0146","article-title":"APOBEC mutagenesis inhibits breast cancer growth through induction of T cell\u2013mediated antitumor immune responses","volume":"10","author":"DiMarco","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2024.112232_b0395","doi-asserted-by":"crossref","unstructured":"Weistuch C, Murgas KA, Zhu J, Norton L, Dill KA, Tannenbaum AR, Deasy JO (2023) Functional transcriptional signatures for tumor-type-agnostic phenotype prediction. bioRxiv 2023-04.","DOI":"10.1101\/2023.04.12.536595"},{"issue":"7","key":"10.1016\/j.intimp.2024.112232_b0400","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","article-title":"Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors","volume":"92","author":"Esteller","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.intimp.2024.112232_b0405","doi-asserted-by":"crossref","first-page":"e27355","DOI":"10.1371\/journal.pone.0027355","article-title":"Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment","volume":"6","author":"Radpour","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112232_b0410","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10549-009-0600-1","article-title":"Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer","volume":"122","author":"Fujikane","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.intimp.2024.112232_b0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-014-0250-y","article-title":"Downregulation of E-cadherin expression in breast cancer by promoter hypermethylation and its relation with progression and prognosis of tumor","volume":"31","author":"Shargh","year":"2014","journal-title":"Med. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b0420","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.lfs.2007.05.012","article-title":"Promoter hypermethylation of TMS1, BRCA1, ER\u03b1 and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients","volume":"81","author":"Mirza","year":"2007","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.intimp.2024.112232_b0425","first-page":"3225","article-title":"A gene hypermethylation profile of human cancer","volume":"61","author":"Esteller","year":"2001","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.112232_b0430","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.51.5.786","article-title":"Acetylation and methylation of histones and their possible role in the regulation of rna synthesis","volume":"51","author":"Allfrey","year":"1964","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b0435","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019521","article-title":"Histone modifications and cancer","volume":"8","author":"Audia","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b0440","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0445","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"Ropero","year":"2007","journal-title":"Mol. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b0450","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1101\/gr.5704207","article-title":"The landscape of histone modifications across 1% of the human genome in five human cell lines","volume":"17","author":"Koch","year":"2007","journal-title":"Genome Res."},{"issue":"50","key":"10.1016\/j.intimp.2024.112232_b0455","doi-asserted-by":"crossref","first-page":"21931","DOI":"10.1073\/pnas.1016071107","article-title":"Histone H3K27ac separates active from poised enhancers and predicts developmental state","volume":"107","author":"Creyghton","year":"2010","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b0460","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/ng.3550","article-title":"Histone H3 globular domain acetylation identifies a new class of enhancers","volume":"48","author":"Pradeepa","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2024.112232_b0465","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11670-011-0201-5","article-title":"High expression of p300 in human breast cancer correlates with tumor recurrence and predicts adverse prognosis","volume":"23","author":"Xiao","year":"2011","journal-title":"Chinese J. Cancer Res."},{"key":"10.1016\/j.intimp.2024.112232_b0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-0875-3","article-title":"SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88","volume":"37","author":"Dong","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.intimp.2024.112232_b0475","doi-asserted-by":"crossref","first-page":"6840","DOI":"10.7150\/thno.36338","article-title":"CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1\/P50","volume":"9","author":"Chi","year":"2019","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b0480","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.bbrc.2015.10.060","article-title":"Transcriptional factors p300 and MRTF-A synergistically enhance the expression of migration-related genes in MCF-7 breast cancer cells","volume":"467","author":"He","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"26","key":"10.1016\/j.intimp.2024.112232_b0485","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1038\/onc.2016.525","article-title":"CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling","volume":"36","author":"Lin","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2024.112232_b0490","doi-asserted-by":"crossref","unstructured":"Wang RH, Zheng Y, Kim HS, Xu X, Cao L, Lahusen T, Lee MH, Xiao C, Vassilopoulos A, Chen W, Gardner K (2008) Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Mol Cell Oct 10;32(1):11-20.","DOI":"10.1016\/j.molcel.2008.09.011"},{"issue":"9","key":"10.1016\/j.intimp.2024.112232_b0495","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1158\/0008-5472.CAN-08-3907","article-title":"Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome","volume":"69","author":"Elsheikh","year":"2009","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.112232_b0500","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.18632\/oncotarget.6922","article-title":"Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes","volume":"7","author":"Messier","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2024.112232_b0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-018-0931-9","article-title":"Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast cancer","volume":"18","author":"Dong","year":"2019","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2024.112232_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110357","article-title":"Histone marks regulate the epithelial-to-mesenchymal transition via alternative splicing","volume":"38","author":"Segelle","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2024.112232_b0515","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13402-019-00439-x","article-title":"Endocrine resistant breast cancer cells with loss of ER\u03b1 expression retain proliferative ability by reducing caspase7-mediated HDAC3 cleavage","volume":"43","author":"Yu","year":"2020","journal-title":"Cell. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112232_b0520","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.yexcr.2017.08.029","article-title":"The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer","volume":"359","author":"Hou","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b0525","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1158\/0008-5472.CAN-08-3717","article-title":"FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2\/histone deacetylase 4 association to the locus","volume":"69","author":"Liu","year":"2009","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b0530","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1093\/nar\/gkaa039","article-title":"HDAC8 cooperates with SMAD3\/4 complex to suppress SIRT7 and promote cell survival and migration","volume":"48","author":"Tang","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BSR20191764","article-title":"Long non-coding RNA ARAP1-AS1 accelerates cell proliferation and migration in breast cancer through miR-2110\/HDAC2\/PLIN1 axis","volume":"40","author":"Lu","year":"2020","journal-title":"Biosci. Rep."},{"issue":"22","key":"10.1016\/j.intimp.2024.112232_b0540","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1038\/s41388-020-1277-5","article-title":"ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes","volume":"39","author":"Cassandri","year":"2020","journal-title":"Oncogene"},{"issue":"38","key":"10.1016\/j.intimp.2024.112232_b0545","doi-asserted-by":"crossref","first-page":"27232","DOI":"10.1074\/jbc.M113.481184","article-title":"Loss of epigenetic kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer","volume":"288","author":"Ray","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.intimp.2024.112232_b0550","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1038\/onc.2013.332","article-title":"Significance of PELP1\/HDAC2\/miR-200 regulatory network in EMT and metastasis of breast cancer","volume":"33","author":"Roy","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0555","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1038\/ncomms6406","article-title":"BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10","volume":"5","author":"Gong","year":"2014","journal-title":"Nat. Comm."},{"issue":"67","key":"10.1016\/j.intimp.2024.112232_b0560","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.23006","article-title":"Dual SIRT1 expression patterns strongly suggests its bivalent role in human breast cancer","volume":"8","author":"Rifa\u00ef","year":"2017","journal-title":"Oncotarget"},{"issue":"55","key":"10.1016\/j.intimp.2024.112232_b0565","doi-asserted-by":"crossref","first-page":"30661","DOI":"10.18632\/oncotarget.25771","article-title":"SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer","volume":"9","author":"Rifa\u00ef","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2024.112232_b0570","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1038\/srep03846","article-title":"Epigenetic silencing of ARRDC3 expression in basal-like breast cancer cells","volume":"4","author":"Soung","year":"2014","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.intimp.2024.112232_b0575","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/sj.bjc.6603384","article-title":"Altered sirtuin expression is associated with node-positive breast cancer","volume":"95","author":"Ashraf","year":"2006","journal-title":"British J. Cancer"},{"issue":"5532","key":"10.1016\/j.intimp.2024.112232_b0580","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Sci"},{"key":"10.1016\/j.intimp.2024.112232_b0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-016-0201-x","article-title":"Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model","volume":"8","author":"Zhao","year":"2016","journal-title":"Clin. Epigenetics"},{"issue":"12","key":"10.1016\/j.intimp.2024.112232_b0590","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.celrep.2016.05.046","article-title":"PI3K\/AKT signaling regulates H3K4 methylation in breast cancer","volume":"15","author":"Spangle","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2024.112232_b0595","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semcancer.2017.08.004","article-title":"Epigenetic drivers of tumourigenesis and cancer metastasis","volume":"51","author":"Chatterjee","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0600","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7150\/ijbs.8.59","article-title":"EZH2 methyltransferase and H3K27 methylation in breast cancer","volume":"8","author":"Yoo","year":"2012","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-018-0122-2","article-title":"Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential","volume":"6","author":"Gan","year":"2018","journal-title":"Biomarker Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.112232_b0610","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.molonc.2012.06.002","article-title":"Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes","volume":"6","author":"Holm","year":"2012","journal-title":"Mol. Oncol."},{"issue":"19","key":"10.1016\/j.intimp.2024.112232_b0615","doi-asserted-by":"crossref","first-page":"9352","DOI":"10.1158\/0008-5472.CAN-06-2384","article-title":"Enhancer of zeste 2 as a marker of preneoplastic progression in the breast","volume":"66","author":"Ding","year":"2006","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b0620","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1158\/0008-5472.CAN-13-1896","article-title":"UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells","volume":"74","author":"Kim","year":"2014","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2024.112232_b0625","doi-asserted-by":"crossref","first-page":"e0166090","DOI":"10.1371\/journal.pone.0166090","article-title":"Regulation of IL-20 expression by estradiol through KMT2B-mediated epigenetic modification","volume":"11","author":"Su","year":"2016","journal-title":"PLoS One"},{"issue":"28","key":"10.1016\/j.intimp.2024.112232_b0630","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1038\/onc.2015.443","article-title":"ASXL2 promotes proliferation of breast cancer cells by linking ER\u03b1 to histone methylation","volume":"35","author":"Park","year":"2016","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.intimp.2024.112232_b0635","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/nsmb.2153","article-title":"Recognition of enhancer element-specific histone methylation by TIP60 in transcriptional activation","volume":"18","author":"Jeong","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"31","key":"10.1016\/j.intimp.2024.112232_b0640","doi-asserted-by":"crossref","first-page":"30451","DOI":"10.18632\/oncotarget.5860","article-title":"DOT1L: A new therapeutic target for aggressive breast cancer","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2024.112232_b0645","article-title":"Histone methyltransferase DOT1L as a promising epigenetic target for treatment of solid tumors","volume":"13","author":"Alexandrova","year":"2022","journal-title":"Front. Gen."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0650","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1038\/ncomms8821","article-title":"DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression","volume":"6","author":"Cho","year":"2015","journal-title":"Nat. Comm."},{"key":"10.1016\/j.intimp.2024.112232_b0655","doi-asserted-by":"crossref","unstructured":"Nassa G, Salvati A, Tarallo R, Gigantino V, Alexandrova E, Memoli D, Sellitto A, Rizzo F, Malanga D, Mirante T, Morelli E (2019) Inhibition of histone methyltransferase DOT1L silences ER\u03b1 gene and blocks proliferation of antiestrogen-resistant breast cancer cells. Sci Adv 5(2):eaav5590.","DOI":"10.1126\/sciadv.aav5590"},{"key":"10.1016\/j.intimp.2024.112232_b0660","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.omto.2019.09.005","article-title":"Targeting histone methyltransferase DOT1L by a novel psammaplin A analog inhibits growth and metastasis of triple-negative breast cancer","volume":"15","author":"Byun","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"issue":"5","key":"10.1016\/j.intimp.2024.112232_b0665","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/nar\/gkt012","article-title":"Histone H4 lysine 20 methylation: Key player in epigenetic regulation of genomic integrity","volume":"41","author":"J\u00f8rgensen","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr3681","article-title":"Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity","volume":"16","author":"Yokoyama","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b0675","doi-asserted-by":"crossref","first-page":"972","DOI":"10.7150\/thno.22328","article-title":"The homeotic protein SIX3 suppresses carcinogenesis and metastasis through recruiting the LSD1\/NuRD (MTA3) complex","volume":"8","author":"Zheng","year":"2018","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.intimp.2024.112232_b0680","first-page":"2030","article-title":"BRMS1 coordinates with LSD1 and suppresses breast cancer cell metastasis","volume":"8","author":"Qiu","year":"2018","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b0685","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.cell.2009.05.050","article-title":"LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b0690","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jmcb\/mjy021","article-title":"LSD1 coordinates with the SIN3A\/HDAC complex and maintains sensitivity to chemotherapy in breast cancer","volume":"10","author":"Yang","year":"2018","journal-title":"J. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.intimp.2024.112232_b0695","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1158\/0008-5472.CAN-12-4300","article-title":"KDM4\/JMJD2 histone demethylases: Epigenetic regulators in cancer cells","volume":"73","author":"Berry","year":"2013","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.intimp.2024.112232_b0700","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1158\/0008-5472.CAN-10-0413","article-title":"The histone demethylase JMJD2B is regulated by estrogen receptor \u03b1 and hypoxia, and is a key mediator of estrogen induced growth","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0705","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/onc.2016.174","article-title":"Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53","volume":"36","author":"Ramadoss","year":"2017","journal-title":"Oncogene"},{"issue":"49","key":"10.1016\/j.intimp.2024.112232_b0710","doi-asserted-by":"crossref","first-page":"84761","DOI":"10.18632\/oncotarget.21380","article-title":"The histone demethylase Kdm3a is required for normal epithelial proliferation, ductal elongation and tumor growth in the mouse mammary gland","volume":"8","author":"Qin","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0715","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2006.09.002","article-title":"Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours","volume":"43","author":"Butcher","year":"2007","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2024.112232_b0720","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00432-008-0534-8","article-title":"Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer","volume":"135","author":"Vallian","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.112232_b0725","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11010-013-1696-5","article-title":"Aberrant promoter hypermethylation of p21 (WAF1\/CIP1) gene and its impact on expression and role of polymorphism in the risk of breast cancer","volume":"382","author":"Askari","year":"2013","journal-title":"Mol. Cell Biochem."},{"issue":"6648","key":"10.1016\/j.intimp.2024.112232_b0730","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/38444","article-title":"Crystal structure of the nucleosome core particle at 2.8 a resolution","volume":"389","author":"Luger","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0735","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-2836(84)90382-6","article-title":"Crystal structure of the nucleosome core particle at 16 a resolution","volume":"176","author":"Bentley","year":"1984","journal-title":"J. Mol. Biol."},{"issue":"19","key":"10.1016\/j.intimp.2024.112232_b0740","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1016\/j.jmb.2013.01.022","article-title":"Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol","volume":"425","author":"Bhan","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.intimp.2024.112232_b0745","unstructured":"American Cancer society (2021) Chemotherapy for Breast Cancer. Available on: https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/treatment\/chemotherapy-for-breast-cancer.html. Accessed 30 October 2023."},{"issue":"21","key":"10.1016\/j.intimp.2024.112232_b0750","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1200\/JCO.2013.54.2258","article-title":"Adjuvant endocrine therapy for women with hormone receptor\u2013positive breast cancer","volume":"32","author":"Burstein","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112232_b0755","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1158\/1535-7163.MCT-17-0461","article-title":"Basal-A triple-negative breast cancer cells selectively rely on RNA splicing for survival","volume":"16","author":"Chan","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0760","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b0765","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.intimp.2024.112232_b0770","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/1878-0261.12094","article-title":"Epithelial-mesenchymal transition in cancer","volume":"11","author":"Moustakas","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.intimp.2024.112232_b0775","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00155","article-title":"Implications of the hybrid epithelial\/mesenchymal phenotype in metastasis","volume":"5","author":"Jolly","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2024.112232_b0780","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0272-6386(95)90610-X","article-title":"Transformations between epithelium and mesenchyme: Normal, pathological, and experimentally induced","volume":"26","author":"Hay","year":"1995","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.intimp.2024.112232_b0785","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrm2957","article-title":"Cell adhesion: Integrating cytoskeletal dynamics and cellular tension","volume":"11","author":"Parsons","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2024.112232_b0790","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molonc.2010.11.003","article-title":"Desconstructing the molecular portraits of breast cancer","volume":"5","author":"Prat","year":"2011","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.intimp.2024.112232_b0795","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1038\/sj.onc.1210593","article-title":"Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: Identification of genes potentially related to epithelial-mesenchymal transition","volume":"26","author":"Lien","year":"2007","journal-title":"Oncogene"},{"issue":"7579","key":"10.1016\/j.intimp.2024.112232_b0800","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature15748","article-title":"Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance","volume":"527","author":"Fischer","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.112232_b0805","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI36183","article-title":"Biomarkers for epithelial-mesenchymal transitions","volume":"119","author":"Zeisberg","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.112232_b0810","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1038\/sj.emboj.7600847","article-title":"PKCepsilon-mediated phosphorylation of vimentin controls integrin recycling and motility","volume":"24","author":"Ivaska","year":"2005","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b0815","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccr.2006.10.008","article-title":"A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes","volume":"10","author":"Neve","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2024.112232_b0820","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1593\/tlo.10244","article-title":"Molecular markers of epithelial-to-mesenchymal transition are associated with tumor aggressiveness in breast carcinoma","volume":"4","author":"Sethi","year":"2011","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.intimp.2024.112232_b0825","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00432-013-1376-6","article-title":"Vimentin as a poor prognostic factor for triple-negative breast cancer","volume":"139","author":"Yamashita","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b0830","doi-asserted-by":"crossref","first-page":"e20610","DOI":"10.1371\/journal.pone.0020610","article-title":"Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells","volume":"6","author":"Al Saleh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112232_b0835","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35000034","article-title":"The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells","volume":"2","author":"Batlle","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2024.112232_b0840","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/35000025","article-title":"The transcription factor snail controls epithelial mesenchymal transitions by repressing E-cadherin expression","volume":"2","author":"Cano","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2024.112232_b0845","first-page":"1613","article-title":"The SLUG zinc-finger protein represses E-cadherin in breast cancer","volume":"62","author":"Hajra","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2024.112232_b0850","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/sj.onc.1208429","article-title":"DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells","volume":"24","author":"Eger","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2024.112232_b0855","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S1097-2765(01)00260-X","article-title":"The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion","volume":"7","author":"Comijn","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2024.112232_b0860","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr3068","article-title":"Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: Usefulness of prognostic markers E-cadherin and Ki67","volume":"13","author":"Kashiwagi","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.intimp.2024.112232_b0865","article-title":"Epithelial-mesenchymal transition markers in breast cancer and pathological response after neoadjuvant chemotherapy","volume":"12","author":"Elzamly","year":"2018","journal-title":"Breast Cancer: Basic Clin. Res."},{"key":"10.1016\/j.intimp.2024.112232_b0870","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/sj.bjc.6604400","article-title":"Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas","volume":"98","author":"Loussouarn","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2024.112232_b0875","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/PAS.0b013e3181592201","article-title":"Laminin 5 expression in metaplastic breast carcinomas","volume":"32","author":"Carpenter","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.intimp.2024.112232_b0880","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1158\/0008-5472.CAN-07-5680","article-title":"Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition","volume":"68","author":"Arima","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2024.112232_b0885","first-page":"721","article-title":"Stromelysin 3: An independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression","volume":"152","author":"Ahmad","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2024.112232_b0890","doi-asserted-by":"crossref","first-page":"12-","DOI":"10.1186\/1471-2407-7-12","article-title":"Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: Involvement of the IGF-1 signalling pathway","volume":"7","author":"Kasper","year":"2007","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0895","doi-asserted-by":"crossref","DOI":"10.24041\/ejmr2019.112","article-title":"Matrix metalloproteases: A review on their proangiogenic and metastatic potential","volume":"6","author":"Srivastava","year":"2019","journal-title":"Era's J. Med. Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0900","doi-asserted-by":"crossref","DOI":"10.24041\/ejmr2019.114","article-title":"Matrix metalloproteinases and their role in breast cancer: A mini review","volume":"6","author":"Gupta","year":"2019","journal-title":"Era's J. Med. Res"},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b0905","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112232_b0910","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: Regulators of the tumor microenviroment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112232_b0915","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.fitote.2018.09.008","article-title":"New inhibitors of matrix metalloproteinases 9 (MMP-9): Lignans from Selaginella moellendorffii","volume":"130","author":"Zhu","year":"2018","journal-title":"Fitoterapia"},{"issue":"2","key":"10.1016\/j.intimp.2024.112232_b0920","first-page":"32","article-title":"Matrix metallo proteinase 2 involvement in breast cancer progression: a mini-review","volume":"15","author":"Jezierska","year":"2009","journal-title":"Med. Sci. Monit."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b0925","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1242\/dev.129.6.1487","article-title":"Involvement of a matrix metallo-proteinase in MIS- induced cell death during urogenital development","volume":"129","author":"Roberts","year":"2002","journal-title":"Develop"},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b0930","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5114\/wo.2016.61565","article-title":"Differential expression of matrix metalloproteinase-13 in association with invasion of breast cancer","volume":"20","author":"Kotepui","year":"2016","journal-title":"Contemp. Oncol.\/wsp\u00f3\u0142czesna Onkol."},{"key":"10.1016\/j.intimp.2024.112232_b0935","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.phymed.2018.09.172","article-title":"Orientin inhibits invasion by suppressing MMP-9 and IL-8 expression via the PKC\u03b1\/ERK\/AP-1\/STAT3-mediated signaling pathways in TPA-treated MCF-7 breast cancer cells","volume":"50","author":"Kim","year":"2018","journal-title":"Phytomed"},{"issue":"11","key":"10.1016\/j.intimp.2024.112232_b0940","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/tox.22620","article-title":"7-Methoxy-luteolin-8-C-\u03b2-6-deoxy-xylo-pyranos-3-uloside exactly (mLU8C-PU) isolated from Arthraxon hispidus inhibits migratory and invasive responses mediated via downregulation of MMP-9 and IL-8 expression in MCF-7 breast cancer cells","volume":"33","author":"Kim","year":"2018","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.intimp.2024.112232_b0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4822-7","article-title":"Predictive and prognostic value of Matrix metalloproteinase (MMP)-9 in neoadjuvant chemotherapy for triple-negative breast cancer patients","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2024.112232_b0950","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/j.1349-7006.2007.00593.x","article-title":"Up-regulation of CD147 and matrix metalloproteinase-2,-9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells","volume":"98","author":"Li","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.intimp.2024.112232_b0955","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3389\/fphar.2019.00462","article-title":"DDR1 and MT1-MMP expression levels are determinant for triggering BIK-mediated apoptosis by 3D type I collagen matrix in invasive basal-like breast carcinoma cells","volume":"10","author":"Saby","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112232_b0960","unstructured":"Sharma CG (1938) Ashwagandharishta - Rastantra Sar Evam Sidhyaprayog Sangrah - Krishna-Gopal Ayurveda Bhawan (Dharmarth Trust) Nagpur 743\u2013744."},{"issue":"7","key":"10.1016\/j.intimp.2024.112232_b0965","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.3390\/molecules14072373","article-title":"Steroidal lactones from Withania somnifera, an ancient plant for novel medicine","volume":"14","author":"Mirjalili","year":"2009","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b0970","first-page":"2278","article-title":"Anticancer potential of medicinal plants Withania somnifera, Tinospora cordifolia and Curcuma longa: A review","volume":"3","author":"Ahmad","year":"2015","journal-title":"World Res. J. Med. Aromat. Plant"},{"issue":"7","key":"10.1016\/j.intimp.2024.112232_b0975","first-page":"164","article-title":"Morphology of Withania somnifera (distribution, morphology, phytosociology of Withania somnifera L. Dunal)","volume":"1","author":"Gaurav","year":"2015","journal-title":"Int. J. Curr. Sci. Res."},{"issue":"5S","key":"10.1016\/j.intimp.2024.112232_b0980","doi-asserted-by":"crossref","DOI":"10.4314\/ajtcam.v8i5S.9","article-title":"An overview on ashwagandha: A Rasayana (rejuvenator) of Ayurveda","volume":"8","author":"Singh","year":"2011","journal-title":"Afr. J. Tradit. Complement Altern. Med."},{"key":"10.1016\/j.intimp.2024.112232_b0985","unstructured":"Sharma PV (1999) Ashwagandha. Dravyaguna Vijana, Chaukhambha Viashwabharti Varanasi 763\u2013765."},{"key":"10.1016\/j.intimp.2024.112232_b0990","unstructured":"Bhandari CR (1970) Ashwagandha (Withania somnifera) Vanaushadhi Chandroday (An Encyclopedia of Indian Herbs) 1 CS Series, Varanasi Vidyavilas Press, Varanasi 96\u201397."},{"key":"10.1016\/j.intimp.2024.112232_b0995","unstructured":"Basu KA (1935) Withania somnifera, Indian medicinal plants, 2nd edn. IIIrd Lalit Mohan Basu, Allahabad 1774\u20131776."},{"key":"10.1016\/j.intimp.2024.112232_b1000","unstructured":"Mishra B (2004) Ashwagandha\u2014Bhavprakash Nigantu (Indian Materia Medica). Varanasi, Chaukhambha Bharti Academy, 393\u2013394."},{"key":"10.1016\/j.intimp.2024.112232_b1005","first-page":"133","article-title":"Effects of longterm administration of the roots of ashwagandha and shatavari in rats","volume":"22","author":"Sharma","year":"1985","journal-title":"Indian Drugs"},{"key":"10.1016\/j.intimp.2024.112232_b1010","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1016\/S0378-8741(99)00177-4","article-title":"Adaptogenic and cardioprotective action of ashwagandha in rats and frogs","volume":"70","author":"Dhuley","year":"2000","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b1015","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1080\/07391102.2020.1835725","article-title":"Exploring nature\u2019s bounty: Identification of Withania somnifera as a promising source of therapeutic agents against COVID-19 by virtual screening and in silico evaluation","volume":"40","author":"Srivastava","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b1020","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/mnfr.201500756","article-title":"Withania somnifera: from prevention to treatment of cancer","volume":"60","author":"Palliyaguru","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.intimp.2024.112232_b1025","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b1030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1517\/14728222.10.1.87","article-title":"From traditional Ayurvedic medicine to modern medicine: Identification of therapeutic targets for suppression of inflammation and cancer","volume":"10","author":"Aggarwal","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.intimp.2024.112232_b1035","unstructured":"Umadevi M, Rajeswari R, Rahale CS, Selvavenkadesh S, Pushpa R, Kumar KS, Bhowmik D (2012) Traditional and medicinal uses of Withania somnifera. Pharma Innov 1(9, Part A):102."},{"key":"10.1016\/j.intimp.2024.112232_b1040","unstructured":"Rastogi RP, Mehrotra BN (1998) Compendium of Indian Medicinal Plants. 2nd Reprint, Central Drug Research Institute, Lucknow and National Institute of Science Communication, Council of Scientific and Industrial Research, New Delhi Vol. 1: 434-436; Vol. 2: 708-710; Vol. 3: 682-684; Vol. 4: 765-766; Vol. 5: 889-891; Vol. 6: 148, 1998."},{"issue":"5","key":"10.1016\/j.intimp.2024.112232_b1045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jobm.200510108","article-title":"Antimicrobial properties of a non-toxic glycoprotein (WSG) from Withania somnifera (Ashwagandha)","volume":"46","author":"Girish","year":"2006","journal-title":"J. Basic Microbiol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b1050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jgr.2017.05.002","article-title":"Influence of phytochemical composition on in vitro antioxidant and reducing activities of Indian ginseng [Withania somnifera (L.) Dunal] root extracts","volume":"42","author":"Ganguly","year":"2018","journal-title":"J. Ginseng Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b1055","first-page":"69","article-title":"Antioxidant status of different parts of Withania somnifera","volume":"8","author":"Sumathi","year":"2008","journal-title":"Plant Arch."},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b1060","first-page":"236","article-title":"Antioxidant activity of glycowithanolides from Withania somnifera","volume":"35","author":"Bhattacharya","year":"1997","journal-title":"Indian J. Exp. Biol."},{"issue":"10","key":"10.1016\/j.intimp.2024.112232_b1065","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bcp.2012.08.027","article-title":"Molecular insight in the multifunctional activities of Withaferin A","volume":"84","author":"Vanden Berghe","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b1070","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/0008-5472.CAN-06-2430","article-title":"Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells","volume":"67","author":"Srinivasan","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2024.112232_b1075","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0960-9822(00)00728-4","article-title":"Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1","volume":"10","author":"Dijkers","year":"2000","journal-title":"Curr. Biol."},{"issue":"18","key":"10.1016\/j.intimp.2024.112232_b1080","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1158\/0008-5472.CAN-08-1510","article-title":"Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo","volume":"68","author":"Stan","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b1085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/1535-7163.MCT-09-0771","article-title":"Notch-1 inhibition by Withaferin-A: A therapeutic target against colon carcinogenesis","volume":"9","author":"Koduru","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"10.1016\/j.intimp.2024.112232_b1090","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1093\/carcin\/bgq175","article-title":"Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells","volume":"31","author":"Lee","year":"2010","journal-title":"Carcinogenesis"},{"issue":"22","key":"10.1016\/j.intimp.2024.112232_b1095","doi-asserted-by":"crossref","first-page":"16513","DOI":"10.3390\/ijms242216513","article-title":"Can ashwagandha benefit the endocrine system?\u2014A review","volume":"24","author":"Wici\u0144ski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2024.112232_b1100","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/carcin\/bgr192","article-title":"Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells","volume":"32","author":"Munagala","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.intimp.2024.112232_b1105","first-page":"147","article-title":"Phytoestrogens medicinal herbs-safe and effective alternative to hormone replacement therapy in menopausal syndrome","author":"Kulkarni","year":"2016","journal-title":"J. Res. Tradit. Med."},{"key":"10.1016\/j.intimp.2024.112232_b1110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.apcsb.2019.01.001","article-title":"Estrogen receptor signaling mechanisms","volume":"116","author":"Fuentes","year":"2019","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.intimp.2024.112232_b1115","doi-asserted-by":"crossref","unstructured":"Kerdivel G., Habauzit D., Pakdel F (2013) Assessment and molecular actions of endocrine-disrupting chemicals that interfere with estrogen receptor pathways. Int J Endocrinol 501851.","DOI":"10.1155\/2013\/501851"},{"key":"10.1016\/j.intimp.2024.112232_b1120","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1476-069X-11-S1-S8","article-title":"Environmental exposure to xenoestrogens and oestrogen related cancers: Reproductive system, breast, lung, kidney, pancreas, and brain","volume":"11","author":"Fucic","year":"2012","journal-title":"Environ. Health"},{"issue":"12","key":"10.1016\/j.intimp.2024.112232_b1125","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/biology9120427","article-title":"Phytoestrogens for cancer prevention and treatment","volume":"9","author":"Torrens-Mas","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.intimp.2024.112232_b1130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.yfrne.2010.03.003","article-title":"The pros and cons of phytoestrogens","volume":"31","author":"Patisaul","year":"2010","journal-title":"Front. Neuroendocrinol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b1135","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3889\/oamjms.2019.086","article-title":"Phytoestrogens and their health effect","volume":"7","author":"Desmawati","year":"2019","journal-title":"Macedonian J. Med. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b1140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/09298673113206660297","article-title":"Phytoestrogens in postmenopause: The state of the art from a chemical, pharmacological and regulatory perspective","volume":"21","author":"Poluzzi","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2024.112232_b1145","series-title":"Flaxseed in human nutrition","author":"Thompson","year":"2003"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.112232_b1150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.mce.2008.10.003","article-title":"The binding of lignans flavonoids and coumestrol to CYP450 aromatase a molecular modelling study","volume":"301","author":"Karkola","year":"2009","journal-title":"Mol. Cell Endocrinol."},{"issue":"10","key":"10.1016\/j.intimp.2024.112232_b1155","first-page":"6337","article-title":"study to evaluate the effect of Ashwagandha (a phytoestrogen) on breast cancer, using MCF7 cell line","volume":"12","author":"Dabhade","year":"2023","journal-title":"Eur. Chem. Bull."},{"key":"10.1016\/j.intimp.2024.112232_b1160","first-page":"334","article-title":"Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): A review","volume":"5","author":"Mishra","year":"2000","journal-title":"Altern. Med. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2024.112232_b1165","first-page":"6337","article-title":"A study to evaluate the effect of Ashwagandha (a phytoestrogen) on breast cancer, using MCF7 cell line","volume":"12","author":"Dabhade","year":"2023","journal-title":"Eur. Chem. Bull."},{"key":"10.1016\/j.intimp.2024.112232_b1170","doi-asserted-by":"crossref","unstructured":"Nasimi Doost Azgomi R, Zomorrodi A, Nazemyieh H, Fazljou SM, Sadeghi Bazargani H, Nejatbakhsh F, Moini Jazani A, Ahmadi AsrBadr Y (2018) Effects of Withania somnifera on reproductive system: a systematic review of the available evidence. BioMed Res Int 2018.","DOI":"10.1155\/2018\/4076430"},{"key":"10.1016\/j.intimp.2024.112232_b1175","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/B978-0-12-802147-7.00052-8","article-title":"Ashwagandha: Multiple health benefits","author":"Bharti","year":"2016","journal-title":"In Nutraceuticals"},{"issue":"10","key":"10.1016\/j.intimp.2024.112232_b1180","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1002\/fsn3.2523","article-title":"Female infertility and herbal medicine: An overview of the new findings","volume":"9","author":"Akbaribazm","year":"2021","journal-title":"Food Sci. Nutr."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b1185","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0039-128X(75)90110-5","article-title":"MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors","volume":"26","author":"Horwitz","year":"1975","journal-title":"Steroids"},{"key":"10.1016\/j.intimp.2024.112232_b1190","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/brainsci13060929","article-title":"Review of plant extracts and active components: mechanisms of action for the treatment of obesity-induced cognitive impairment","volume":"13","author":"de la Pe\u00f1a","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.intimp.2024.112232_b1195","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/antiox12030550","article-title":"Withania somnifera L.: Phenolic compounds composition and biological activity of commercial samples and its aqueous and hydromethanolic extracts","volume":"12","author":"Polumackanycz","year":"2023","journal-title":"Antioxidants"},{"issue":"11","key":"10.1016\/j.intimp.2024.112232_b1200","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: How are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radic. Bio Med."},{"key":"10.1016\/j.intimp.2024.112232_b1205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.rbmo.2017.11.007","article-title":"Role of Withania somnifera (Ashwagandha) in the management of male infertility","volume":"36","author":"Sengupta","year":"2018","journal-title":"Reprod. Biomed."},{"key":"10.1016\/j.intimp.2024.112232_b1210","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/acm.2017.0183","article-title":"Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: A double-blind, randomized placebo-controlled trial","volume":"24","author":"Sharma","year":"2018","journal-title":"J. Altern. Complement Med."},{"key":"10.1016\/j.intimp.2024.112232_b1215","doi-asserted-by":"crossref","unstructured":"Mahdi AA, Shukla KK, Ahmad MK, Rajender S, Shankhwar SN, Singh V, Dalela D (2011) Withania somnifera Improves Semen Quality in Stress-Related Male Fertility. Evid Based Complement Altern Med 576962.","DOI":"10.1093\/ecam\/nep138"},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b1220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.imr.2016.10.002","article-title":"Effect of combination of Withania somnifera Dunal and Tribulus terrestris Linn on letrozole induced polycystic ovarian syndrome in rats","volume":"5","author":"Saiyed","year":"2016","journal-title":"Integrative Med. Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.112232_b1225","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ptr.3088","article-title":"The methanolic extract of Withania somnifera ACTS on GABAA receptors in gonadotropin releasing hormone (GnRH) neurons in mice","volume":"24","author":"Bhattarai","year":"2010","journal-title":"Phytother. Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b1230","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/ijms17030290","article-title":"Withaferin-A-A natural anticancer agent with pleitropic mechanisms of action","volume":"17","author":"Lee","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112232_b1235","doi-asserted-by":"crossref","unstructured":"Gupta SC, Prasad S, Aggarwal BB, editors (2016) Anti-inflammatory nutraceuticals and chronic diseases. New York, NY, USA:: Springer.","DOI":"10.1007\/978-3-319-41334-1"},{"issue":"8","key":"10.1016\/j.intimp.2024.112232_b1240","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mc.20760","article-title":"Withaferin a suppresses estrogen receptor-\u03b1 expression in human breast cancer cells","volume":"50","author":"Hahm","year":"2011","journal-title":"Mol. Carcinogenesis"},{"issue":"7","key":"10.1016\/j.intimp.2024.112232_b1245","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1158\/1940-6207.CAPR-13-0445","article-title":"Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells","volume":"7","author":"Kim","year":"2014","journal-title":"Cancer Prev. Res. (Phila)"},{"issue":"11","key":"10.1016\/j.intimp.2024.112232_b1250","first-page":"6327","article-title":"Effect of Withania somnifera root extract on spontaneous estrogen receptor-negative mammary cancer in MMTV\/Neu mice","volume":"34","author":"Khazal","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.intimp.2024.112232_b1255","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110383","article-title":"Withaferin A suppresses breast cancer cell proliferation by inhibition of the two-pore domain potassium (K2P9) channel TASK-3","volume":"129","author":"Z\u00fa\u00f1iga","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.intimp.2024.112232_b1260","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2174\/1389201021666200129121843","article-title":"In Silico Elucidation of the plausible inhibitory potential of withaferin A of Withania Somnifera medicinal herb against breast cancer targeting estrogen receptor","volume":"21","author":"Ali","year":"2020","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.intimp.2024.112232_b1265","doi-asserted-by":"crossref","unstructured":"Devibala G (2022) Molecular Docking Of Withaferin A From Withania Somnifera With The Proteins Associated With Cancer Therapy. J Pharm Negat 1400-8.","DOI":"10.47750\/pnr.2022.13.S10.163"},{"key":"10.1016\/j.intimp.2024.112232_b1270","doi-asserted-by":"crossref","unstructured":"vel Szic KS, Declerck K, Crans RA, Diddens J, Scherf DB, Gerh\u00e4user C, Berghe WV (2017) Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A. Oncotarget 8(25):40434.","DOI":"10.18632\/oncotarget.17107"},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b1275","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/ijms19041033","article-title":"TASK-3 downregulation triggers cellular senescence and growth inhibition in breast cancer cell lines","volume":"19","author":"Z\u00fa\u00f1iga","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b1280","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1535-6108(03)00054-0","article-title":"Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene","volume":"3","author":"Mu","year":"2003","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b1285","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/01635580802381477","article-title":"Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells","volume":"60","author":"Stan","year":"2008","journal-title":"Nutr. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2024.112232_b1290","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1600-0463.2004.apm1120905.x","article-title":"Altered expression of KCNK9 in colorectal cancers","volume":"112","author":"Kim","year":"2004","journal-title":"APMIS"},{"key":"10.1016\/j.intimp.2024.112232_b1295","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00403-014-1511-5","article-title":"Silencing the KCNK9 potassium channel (TASK-3) gene disturbs mitochondrial function, causes mitochondrial depolarization, and induces apoptosis of human melanoma cells","volume":"306","author":"Nagy","year":"2014","journal-title":"Arch. Dermatol. Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b1300","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1748-1716.2011.02359.x","article-title":"Reduction of breast cancer cell migration via up-regulation of TASK-3 two-pore domain K+ channel","volume":"204","author":"Lee","year":"2012","journal-title":"Acta Physiol."},{"key":"10.1016\/j.intimp.2024.112232_b1305","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1007\/s00018-006-6166-8","article-title":"Melanoma cells exhibit strong intracellular TASK-3-specific immunopositivity in both tissue sections and cell culture","volume":"63","author":"Pocsai","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b1310","doi-asserted-by":"crossref","first-page":"e39065","DOI":"10.1371\/journal.pone.0039065","article-title":"Withaferin a alters intermediate filament organization, cell shape and behavior","volume":"7","author":"Grin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112232_b1315","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.12659\/MSM.916931","volume":"25","author":"Liu","year":"2019","journal-title":"Med. Sci. Monit. : Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.intimp.2024.112232_b1320","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.mito.2019.01.003","article-title":"Withaferin A-mediated apoptosis in breast cancer cells is associated with alterations in mitochondrial dynamics","volume":"47","author":"Sehrawat","year":"2019","journal-title":"Mitochondrion"},{"key":"10.1016\/j.intimp.2024.112232_b1325","doi-asserted-by":"crossref","first-page":"E891","DOI":"10.1152\/ajpendo.00353.2001","article-title":"Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-a","volume":"282","author":"Preisler-Mashek","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2024.112232_b1330","first-page":"185","article-title":"Isothiocyanates repress estrogen receptor a expression in breast cancer cells","volume":"21","author":"Kang","year":"2009","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.intimp.2024.112232_b1335","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1074\/jbc.M109.093765","article-title":"Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis","volume":"285","author":"Bargagna-Mohan","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b1340","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2007.04.010","article-title":"The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin","volume":"14","author":"Bargagna-Mohan","year":"2007","journal-title":"Chem. Biol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112232_b1345","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/ijc.25938","article-title":"Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation","volume":"129","author":"Thaiparambil","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2024.112232_b1350","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1158\/0008-5472.CAN-13-2081","article-title":"Mechanistic elucidation of the antitumor properties of withaferin A in breast cancer","volume":"74","author":"Nagalingam","year":"2014","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b1355","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neo.2017.04.005","article-title":"Withaferin A inhibits prostate carcinogenesis in a PTEN-deficient mouse model of prostate cancer","volume":"19","author":"Moselhy","year":"2017","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b1360","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1039\/c0np00045k","article-title":"Natural withanolides: An overview","volume":"28","author":"Chen","year":"2011","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.intimp.2024.112232_b1365","series-title":"Progress in the chemistry of organic natural products","author":"Gill","year":"2012"},{"issue":"22","key":"10.1016\/j.intimp.2024.112232_b1370","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1080\/14786419.2014.919286","article-title":"Antiproliferative withanolides from several solanaceous species","volume":"28","author":"Zhang","year":"2014","journal-title":"Nat. Prod. Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.112232_b1375","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1351\/PAC-CON-11-10-08","article-title":"Antiproliferative withanolides from the Solanaceae: A structure\u2013activity study","volume":"84","author":"Zhang","year":"2012","journal-title":"Pure Appl. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2024.112232_b1380","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1021\/acs.jnatprod.5b00698","article-title":"Withanolides and Sucrose Esters from Physalis neomexicana","volume":"78","author":"Cao","year":"2015","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.intimp.2024.112232_b1385","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1074\/jbc.M606728200","article-title":"Withaferin A strongly elicits I\u03baB kinase \u03b2 hyperphosphorylation concomitant with potent inhibition of its kinase activity","volume":"282","author":"Kaileh","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.112232_b1390","doi-asserted-by":"crossref","first-page":"17184","DOI":"10.1074\/jbc.M709447200","article-title":"Tubocapsenolide A, a novel withanolide, inhibits proliferation and induces apoptosis in MDA-MB-231 cells by thiol oxidation of heat shock proteins","volume":"283","author":"Chen","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2024.112232_b1395","doi-asserted-by":"crossref","first-page":"e0275432","DOI":"10.1371\/journal.pone.0275432","article-title":"Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational, molecular docking and conceptual DFT studies","volume":"17","author":"Gowtham","year":"2022","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2024.112232_b1400","doi-asserted-by":"crossref","first-page":"e37764","DOI":"10.1371\/journal.pone.0037764","article-title":"Withanolides-induced breast cancer cell death is correlated with their ability to inhibit heat protein 90","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112232_b1405","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1128\/MCB.17.7.3629","article-title":"Constitutive activation of NF-kappaB during progression of breast cancer tohormone-independent growth","volume":"17","author":"Nakshatri","year":"1997","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112232_b1410","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.foodchem.2009.02.061","article-title":"New cytotoxic withanolides from Physalis peruviana","volume":"116","author":"Lan","year":"2009","journal-title":"Food Chem."},{"issue":"9","key":"10.1016\/j.intimp.2024.112232_b1415","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/antiox9090873","article-title":"Withanolide C inhibits proliferation of breast cancer cells via oxidative stress-mediated apoptosis and DNA damage","volume":"9","author":"Yu","year":"2020","journal-title":"Antioxidants"},{"issue":"7","key":"10.1016\/j.intimp.2024.112232_b1420","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/ptr.2736","article-title":"Withanolide sulfoxide from Aswagandha roots inhibits nuclear transcription factor-kappa-B, cyclooxygenase and tumor cell proliferation","volume":"23","author":"Mulabagal","year":"2009","journal-title":"Phytother. Res."},{"issue":"13","key":"10.1016\/j.intimp.2024.112232_b1425","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1080\/07391102.2021.1877823","article-title":"Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer","volume":"40","author":"Purawarga Matada","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.intimp.2024.112232_b1430","first-page":"1342","article-title":"In-silico screening and molecular docking studies of active constituents of Withania somnifera to investigate its kinase inhibitory activities","volume":"13","author":"Hebbar","year":"2022","journal-title":"J. Pharm. Negat. Results"},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b1435","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lfs.2003.07.007","article-title":"Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves","volume":"74","author":"Jayaprakasam","year":"2003","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.intimp.2024.112232_b1440","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0192-0561(97)85551-8","article-title":"Beta-sitosterol and beta-sitosterol glucoside stimulate human peripheral blood lymphocyte proliferation: Implications for their use as an immunomodulatory vitamin combination","volume":"18","author":"Bouic","year":"1996","journal-title":"Int. J. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112232_b1445","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/jn\/130.9.2127","article-title":"Phytosterols as anticancer dietary components: evidence and mechanism of action","volume":"130","author":"Awad","year":"2000","journal-title":"J. Nutr."},{"issue":"2A","key":"10.1016\/j.intimp.2024.112232_b1450","first-page":"821","article-title":"Dietary phytosterol inhibits the growth and metastasis of MDA-MB-231 human breast cancer cells grown in SCID mice","volume":"20","author":"Awad","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1016\/j.intimp.2024.112232_b1455","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jn\/130.9.2127","article-title":"Phytosterols as anticancer dietary components: Evidence and mechanism of action","volume":"130","author":"Awad","year":"2000","journal-title":"J. Nutr."},{"issue":"31","key":"10.1016\/j.intimp.2024.112232_b1460","doi-asserted-by":"crossref","first-page":"20319","DOI":"10.1039\/D2RA03092F","article-title":"Anticancer potential of \u03b2-sitosterol and oleanolic acid as through inhibition of human estrogenic 17beta-hydroxysteroid dehydrogenase type-1 based on an in silico approach","volume":"12","author":"Kristanti","year":"2022","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b1465","doi-asserted-by":"crossref","first-page":"15","DOI":"10.13181\/mji.v23i1.684","article-title":"In silico study of curcumol, curcumenol, isocurcumenol, and \u03b2-sitosterol as potential inhibitors of estrogen receptor alpha of breast cancer","volume":"23","author":"Mustarichiei","year":"2014","journal-title":"Med. J. Indonesia"},{"key":"10.1016\/j.intimp.2024.112232_b1470","doi-asserted-by":"crossref","unstructured":"Hasibuan PA, Sitorus P, Satria D (2017) Anticancer Activity of \u0392-Sitosterol from Plectranthus amboinicus (Lour. Spreng.) Leaves: In Vitro and In Silico Studies. Asian J Pharm Clin Res 10(5):306-8.","DOI":"10.22159\/ajpcr.2017.v10i5.16931"},{"key":"10.1016\/j.intimp.2024.112232_b1475","doi-asserted-by":"crossref","unstructured":"Brown AC, Stevenson LM, Leonard HM, Nieves-Puigdoller K, Clotfelter ED (2014) Phytoestrogens \u03b2-sitosterol and genistein have limited effects on reproductive endpoints in a female fish, Betta splendens. BioMed Res Int 2014.","DOI":"10.1155\/2014\/681396"},{"issue":"7","key":"10.1016\/j.intimp.2024.112232_b1480","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3390\/molecules23071557","article-title":"Synergistic effect of bioactive anticarcinogens from soybean on anti-proliferative activity in MDA-MB-231 and MCF-7 human breast cancer cells in vitro","volume":"23","author":"Zhu","year":"2018","journal-title":"Mol. (Basel Switzerland)"},{"key":"10.1016\/j.intimp.2024.112232_b1485","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1472-6882-13-280","article-title":"\u03b2-sitosterol induces G1 arrest and causes depolarization of mitochondrial membrane potential in breast carcinoma MDA-MB-231 cells","volume":"13","author":"Vundru","year":"2013","journal-title":"BMC Complement Altern. Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.112232_b1490","first-page":"497","article-title":"\u03b2-sitosterol, a plant sterol, induces apoptosis and activates key caspases in MDA-MB-231 human breast cancer cells","volume":"10","author":"Awad","year":"2003","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2024.112232_b1495","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/nu5020359","article-title":"Plant sterols as anticancer nutrients: Evidence for their role in breast cancer","volume":"5","author":"Grattan","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2024.112232_b1500","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/jn\/134.5.1145","article-title":"\u03b2-sitosterol, \u03b2-sitosterol glucoside, and a mixture of \u03b2-sitosterol and \u03b2-sitosterol glucoside modulate the growth of estrogen-responsive breast cancer cells in vitro and in ovariectomized athymic mice","volume":"134","author":"Ju","year":"2004","journal-title":"J. Nutr."},{"issue":"12","key":"10.1016\/j.intimp.2024.112232_b1505","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1158\/1535-7163.MCT-14-0324","article-title":"Withanone-rich combination of ashwagandha withanolides restricts metastasis and angiogenesis through hnRNP-K Ashwagandha inhibits metastasis and angiogenesis","volume":"13","author":"Gao","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.intimp.2024.112232_b1510","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/2394-4722.157601","article-title":"Withania somnifera extract reduces the invasiveness of MDA-MB-231 breast cancer and inhibits cytokines associated with metastasis","volume":"1","author":"Khazal","year":"2015","journal-title":"J. Cancer Metastasis Treat."},{"issue":"5","key":"10.1016\/j.intimp.2024.112232_b1515","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4103\/0250-474X.78543","article-title":"In vitro anticancer activity of the root, stem and leaves of Withania Somnifera against various human cancer cell lines","volume":"72","author":"Yadav","year":"2010","journal-title":"Indian J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2024.112232_b1520","first-page":"2723","article-title":"Antiproliferative activity of the methanolic extract of Withania somnifera leaves from Faifa mountains, Southwest Saudi Arabia, against several human cancer cell lines","volume":"17","author":"Alfaifi","year":"2016","journal-title":"Asian Pac. J. Cancer Preven."},{"key":"10.1016\/j.intimp.2024.112232_b1525","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.863619","article-title":"Combination of Ashwagandha water extract and intermittent fasting as a therapy to overcome cisplatin resistance in breast cancer: An in vitro and in vivo study","volume":"9","author":"Jawarneh","year":"2022","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.intimp.2024.112232_b1530","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/separations8010008","article-title":"Antitumor potential of green synthesized ZnONPs using root extract of Withania somnifera against human breast cancer cell line","volume":"8","author":"Prasad","year":"2021","journal-title":"Separations"},{"issue":"9","key":"10.1016\/j.intimp.2024.112232_b1535","doi-asserted-by":"crossref","first-page":"e75069","DOI":"10.1371\/journal.pone.0075069","article-title":"Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.intimp.2024.112232_b1540","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/0253-7176.106022","article-title":"A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults","volume":"34","author":"Chandrasekhar","year":"2012","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.intimp.2024.112232_b1545","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/acm.2014.0177","article-title":"An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera)","volume":"20","author":"Pratte","year":"2014","journal-title":"J. Altern. Complement Med."},{"key":"10.1016\/j.intimp.2024.112232_b1550","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.ejca.2012.02.031","article-title":"AOS14 Phase II clinical study of combination chemotherapy with herb Withania somnifera (ashwagandha) in breast cancer","volume":"48","author":"Biswal","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.intimp.2024.112232_b1555","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1128\/MCB.01657-08","article-title":"Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells","volume":"29","author":"Ndlovu","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2024.112232_b1560","doi-asserted-by":"crossref","first-page":"e87850","DOI":"10.1371\/journal.pone.0087850","article-title":"Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells","volume":"9","author":"Szarc Vel Szic","year":"2014","journal-title":"PLoS One"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924007513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924007513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:42:47Z","timestamp":1791301367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924007513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":312,"alternative-id":["S1567576924007513"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112232","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on existing therapeutic options and status of novel anti-metastatic agents in breast cancer: Elucidating the molecular mechanisms underlying the pleiotropic action of Withania somnifera (Indian ginseng) in breast cancer attenuation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112232"}}